How to Use Abaloparatide
Complete guide to Abaloparatide dosing, administration, timing, and protocol recommendations.
Quick Overview
Abaloparatide (brand name Tymlos) is a synthetic 34-amino-acid analog of parathyroid hormone-related protein (PTHrP), and like teriparatide it is an anabolic osteoporosis drug that builds new bone. The FDA approved it in April 2017 for postmenopausal women at high fracture risk, and in December 2022 added men with osteoporosis at high fracture risk. It is the second drug in its class and was designed to lean harder on bone formation with less of the bone-breakdown and calcium-spike baggage.
Dosing Guidelines
Common Dose
80 mcg daily
Frequency
Once daily
Dose Range
80 mcg daily
Note: PTHrP analog for osteoporosis. Similar to teriparatide but different binding profile.
Administration Method
Subcutaneous injection daily
Best Time to Take
Morning or as directed
Timing may vary based on individual response and goals. Consistency is generally more important than specific timing.
Protocol Duration
Maximum 2 years (same lifetime limit as teriparatide)
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Hypercalciuria (11%)
- •Dizziness (10%)
- •Nausea (8%)
- •Palpitations (5%)
- •Injection site reactions
Frequently Asked Questions
What is the recommended dose for Abaloparatide?
80 mcg daily
How do you administer Abaloparatide?
Subcutaneous injection daily
When is the best time to take Abaloparatide?
Morning or as directed
How long should you use Abaloparatide?
Maximum 2 years (same lifetime limit as teriparatide)
This information is for educational purposes only. Always consult with a healthcare professional before using any peptide. Dosing information is based on research literature and community reports, not medical advice.